Winslow Capital Management’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $2K | Hold |
|
|||||
|
2018
Q1 | $2K | Hold |
|
|||||
|
2017
Q4 | $2K | Hold |
|
|||||
|
2017
Q3 | $2K | Hold |
|
|||||
|
2017
Q2 | $2K | Sell |
|
|||||
|
2017
Q1 | $7K | Sell |
|
|||||
|
2016
Q4 | $261M | Buy |
|
|||||
|
2016
Q3 | $39K | Sell |
|
|||||
|
2016
Q2 | $40K | Sell |
|
|||||
|
2016
Q1 | $436M | Buy |
|
|||||
|
2015
Q4 | $584M | Sell |
|
|||||
|
2015
Q3 | $502M | Buy |
|
|||||
|
2015
Q2 | $522M | Buy |
|
|||||
|
2015
Q1 | $342M | Sell |
|
|||||
|
2014
Q4 | $620M | Sell |
|
|||||
|
2014
Q3 | $558M | Buy |
|
|||||
|
2014
Q2 | $449M | Buy |
|
|||||
|
2014
Q1 | $430M | Sell |
|
|||||
|
2013
Q4 | $452M | Buy |
|
|||||
|
2013
Q3 | $321M | Sell |
|
|||||
|
2013
Q2 | $386M | Buy |
|